Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
Summary: January 25, 2026 news reports AVITA Medical’s 19 abstracts (14 podium) at 2026 Boswick Burn & Wound Symposium, featuring the first surgeon-reported integration of RECELL (autologous cell harvesting for healing), PermeaDerm (temporary coverage with early vascularization/organized tissue), and Cohealyx (wound prep) in single pathways. Cases: Young trauma patient and elderly with large full-thickness wound—PermeaDerm for coverage, Cohealyx prep, RECELL + grafting for closure; reduced dressing changes/follow-ups, potential for community/rural settings. Additional: PermeaDerm trial histology (early vessels, no excess inflammation vs. donor skin); RECELL real-world consistency in healing/complications/hospital stay.
Key Highlights:
- Integration: First combined use for challenging wounds.
- Benefits: Efficient pathway, less frequent interventions.
- Evidence: Histology/clinical trends; full PermeaDerm/Cohealyx results 2026.
- Relevance: Advances regenerative/combined tech for burns/complex wounds.
Keywords: AVITA Medical, RECELL, PermeaDerm, Boswick Symposium